Finnish and Swedish researchers found that the Pandemrix vaccine significantly increased children and youths’ risk of getting narcolepsy.
The European Medicines Agency decided that the use of Pandemrix should be restricted for those under the age of 20.
Finland’s Minister for Social Affairs and Health, Paula Risikko, says that this expert judgement is important as concerns the issue of compensation for those who have fallen ill with narcolepsy after receiving the swine flu vaccine.
Risikko believes that compensation will be paid at some point.
The National Institute for Health and Welfare will publish its own final report on the issue at the end of August.